Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
German start-up Verovaccines will further develop its pipeline at a new R&D facility in Halle.
Animal Pharm is looking for new authors for its animal health industry reports team.
Swedish firm Intervacc has received funding from the Eurostars-2 program to aid development of a vaccine against Streptococcus suis in pigs.
The National Pork Producers Council (NPPC) has called for funding for a foot-and-mouth disease (FMD) vaccine bank in the next Farm Bill.
Boehringer Ingelheim has continued to develop its network of vaccine capabilities by spending over €200 million ($235 million) to establish a new vaccine production center in France.
Phibro Animal Health plans to establish a new vaccine production facility in Sligo, Ireland.
VTT Technical Research Centre of Finland has gained promising results from the first trials of a vaccine against post-weaning diarrhea (PWD) in pigs.
Researchers at the UK's Pirbright Institute claim to have developed a recombinant vaccine effective against both Marek's disease (MD) and infectious bursal disease (IBD) using a new viral vector.
Zoetis aims to improve reactions to new outbreaks through the establishment of the Center for Transboundary and Emerging Diseases.
Hipra has extended the European availability of its Vimco vaccine for the prevention of mastitis in sheep and goats.
Zoetis has launched its Suvaxyn Circo vaccine against porcine circovirus type 2 (PCV2) in Europe.
Leading veterinary vaccine developers Zoetis, Boehringer Ingelheim Animal Health and Ceva Santé Animale have extended their portfolios in Canada.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.